Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.

Literature DB >> 16365174

Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.

Paul Richardson, Kenneth Anderson.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 16365174 DOI： 10.1200/JCO.2005.03.8851

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo.

Authors: Kihyun Kim; Sun-Young Kong; Mariateresa Fulciniti; Xianfeng Li; Weihua Song; Sabikun Nahar; Peter Burger; Mathew J Rumizen; Klaus Podar; Dharminder Chauhan; Teru Hideshima; Nikhil C Munshi; Paul Richardson; Ann Clark; Janet Ogden; Andreas Goutopoulos; Luca Rastelli; Kenneth C Anderson; Yu-Tzu Tai
Journal: Br J Haematol Date: 2010-03-12 Impact factor: 6.998

2. Response and Survival Estimates of Patients With Plasma Cell Myeloma in a Resource-Constrained Setting Using Protocols From High-Income Countries: A Single-Center Experience From Sri Lanka.

Authors: Saman Hewamana; Prasanna Gunasena; Chathuri Jayasinghe; Thurairajah Skandarajah; Mahesh Harischandra; Sobitha Abeyaratne; Lalith Ekanayake; Gnani Somasundaram; Surjit Somiah; Vadivelu Srinivasan; Gehan Arseculeratne; Neomal Perera; Jayaindra Fernando; Mazhar Faiz; Nihal Munasinghe; Ashfaq Mowlana; Samadhi Deshapriya; Supun Mawathakubura; Chandana Wickramarathna; Ananda Wijewickrama; Priyankara Jayawardena; Eranga Perera; Natasha Peiris; Sarath Paranawithane; Chitranganie Perera; Chitranga Kariyawasam; Sanjeewa Munasinghe; Chandu De Silva; Rohini Wadanamby; Geethani Galagoda; Thet Thet Lin; Bandula Wijesiriwardena; Jayantha Balawardena
Journal: JCO Glob Oncol Date: 2022-06

Review 3. Treatment strategies in elderly patients with multiple myeloma: current status.

Authors: Hang Quach; H Miles Prince; Linda Mileshkin
Journal: Drugs Aging Date: 2007 Impact factor: 3.923

4. Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.

Authors: Joseph D Tariman; Ginger Love; Emily McCullagh; Stacey Sandifer
Journal: Clin J Oncol Nurs Date: 2008-06 Impact factor: 1.027

5. Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.

Authors: Page Bertolotti; Elizabeth Bilotti; Kathleen Colson; Kathleen Curran; Deborah Doss; Beth Faiman; Maria Gavino; Bonnie Jenkins; Kathy Lilleby; Ginger Love; Patricia A Mangan; Emily McCullagh; Teresa Miceli; Kena Miller; Kathryn Rogers; Sandra Rome; Stacey Sandifer; Lisa C Smith; Joseph D Tariman; Jeanne Westphal
Journal: Clin J Oncol Nurs Date: 2008-06 Impact factor: 1.027

6. Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis.

Authors: Yu-Tzu Tai; Mariateresa Fulciniti; Teru Hideshima; Weihua Song; Merav Leiba; Xian-Feng Li; Matthew Rumizen; Peter Burger; Aileen Morrison; Klaus Podar; Dharminder Chauhan; Pierfrancesco Tassone; Paul Richardson; Nikhil C Munshi; Irene M Ghobrial; Kenneth C Anderson
Journal: Blood Date: 2007-05-17 Impact factor: 22.113